Literature DB >> 2676937

Inhibition of bacterial isoprenoid synthesis by fosmidomycin, a phosphonic acid-containing antibiotic.

Y Shigi1.   

Abstract

The mechanism of action of fosmidomycin (FR-31564), a phosphonic acid containing antibiotic, was examined against Escherichia coli, Micrococcus luteus and other bacteria. It converted growing Esch. coli cells into spheroplasts or swollen cells, but did not inhibit the enzymatic reactions of cell wall synthesis in ether-treated cells. Unlike bicyclomycin, phenethyl alcohol and mitomycin C, it did not reduce the amount of envelope lipoprotein, phospholipids, or DNA, but did reduce the amount of menaquinones and ubiquinones in growing Esch. coli cells. It also inhibited the biosynthesis of both carotenoids and menaquinones in M. luteus cells, suggesting that inhibition of the biosynthesis of a common precursor of these isoprenoids (possibly farnesyl pyrophosphate) might be the main site of its antibacterial activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2676937     DOI: 10.1093/jac/24.2.131

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  18 in total

1.  GcpE is involved in the 2-C-methyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis in Escherichia coli.

Authors:  B Altincicek; A K Kollas; S Sanderbrand; J Wiesner; M Hintz; E Beck; H Jomaa
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

2.  1-Deoxy-D-xylulose 5-phosphate reductoisomerase (IspC) from Mycobacterium tuberculosis: towards understanding mycobacterial resistance to fosmidomycin.

Authors:  Rakesh K Dhiman; Merrill L Schaeffer; Ann Marie Bailey; Charles A Testa; Hataichanok Scherman; Dean C Crick
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

Review 3.  The Mycobacterium tuberculosis MEP (2C-methyl-d-erythritol 4-phosphate) pathway as a new drug target.

Authors:  Hyungjin Eoh; Patrick J Brennan; Dean C Crick
Journal:  Tuberculosis (Edinb)       Date:  2008-09-14       Impact factor: 3.131

4.  Isoprenoid biosynthesis. Metabolite profiling of peppermint oil gland secretory cells and application to herbicide target analysis.

Authors:  B M Lange; R E Ketchum; R B Croteau
Journal:  Plant Physiol       Date:  2001-09       Impact factor: 8.340

5.  Evidence of a role for LytB in the nonmevalonate pathway of isoprenoid biosynthesis.

Authors:  F X Cunningham; T P Lafond; E Gantt
Journal:  J Bacteriol       Date:  2000-10       Impact factor: 3.490

6.  A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling.

Authors:  Baichen Zhang; Kristin M Watts; Dana Hodge; Lisa M Kemp; David A Hunstad; Leslie M Hicks; Audrey R Odom
Journal:  Biochemistry       Date:  2011-04-11       Impact factor: 3.162

7.  Isoprenoid biosynthesis as a target for antibacterial and antiparasitic drugs: phosphonohydroxamic acids as inhibitors of deoxyxylulose phosphate reducto-isomerase.

Authors:  Lionel Kuntz; Denis Tritsch; Catherine Grosdemange-Billiard; Andréa Hemmerlin; Audrey Willem; Thomas J Bach; Michel Rohmer
Journal:  Biochem J       Date:  2005-02-15       Impact factor: 3.857

Review 8.  Biosynthesis of phosphonic and phosphinic acid natural products.

Authors:  William W Metcalf; Wilfred A van der Donk
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 9.  From molecular fossils of bacterial hopanoids to the formation of isoprene units: discovery and elucidation of the methylerythritol phosphate pathway.

Authors:  Michel Rohmer
Journal:  Lipids       Date:  2008-11-15       Impact factor: 1.880

Review 10.  Genomics-enabled discovery of phosphonate natural products and their biosynthetic pathways.

Authors:  Kou-San Ju; James R Doroghazi; William W Metcalf
Journal:  J Ind Microbiol Biotechnol       Date:  2013-11-24       Impact factor: 3.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.